Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Authors' reply

Biopsy and personalized medicine

In their correspondence, Amalou and Wood rightly highlight the transition of advanced biopsy and imaging techniques from diagnostic to personalized prognostic tools.1 My Perspectives article2 used as its illustrative model the non-neoplastic disease of pancreatitis, in which determining susceptibility attributable to germ line variations in the DNA sequence is more informative than examining pancreatic tissue, whether from biopsy or on imaging. However, as Amalou and Wood point out, in the area of oncology, advanced imaging and biopsy techniques for next-generation 'omics' analyses will have a major role in the ultimate delivery of personalized medicine. For example, studies published in the past 2 years that examined the heterogeneity and evolution of somatic DNA changes in pancreatic3 and other cancers4 have revealed dynamic remodelling of the cancer genome. In this instance, further development and implementation of such imaging and biopsy techniques will support the development of predictive modelling that might help us to identify patients with pancreatic cancer early and to improve their treatment. I also agree that a focus on the tumour tissue itself will be essential for drug discovery and personalization in cancer care, although a parallel benefit does not exist in the chronic inflammatory conditions that served as the focus of my article.

References

  1. 1

    Amalou, H. & Wood, B. J. Biopsy and personalized medicine. Nat. Rev. Gastroenterol. Hepatol. http://dx.doi.org/10.1038/nrgastro.2012.100-c1.

  2. 2

    Whitcomb, D. C. What is personalized medicine and what should it replace? Nat. Rev. Gastroenterol. Hepatol. 9, 418–424 (2012).

    Article  Google Scholar 

  3. 3

    Campbell, P. J. et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 467, 1109–1113 (2010).

    CAS  Article  Google Scholar 

  4. 4

    Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883–892 (2012).

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to David C. Whitcomb.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Whitcomb, D., Lee, A. Biopsy and personalized medicine. Nat Rev Gastroenterol Hepatol 9, 683 (2012). https://doi.org/10.1038/nrgastro.2012.100-c2

Download citation

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing